BlackRock’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-34,714
| Closed | -$25.3K | – | 5494 |
|
|
2023
Q4 | $25.3K | Hold |
34,714
| – | – | ﹤0.01% | 5057 |
|
|
2023
Q3 | $38.9K | Hold |
34,714
| – | – | ﹤0.01% | 5045 |
|
|
2023
Q2 | $46.9K | Hold |
34,714
| – | – | ﹤0.01% | 5076 |
|
|
2023
Q1 | $36.8K | Hold |
34,714
| – | – | ﹤0.01% | 5169 |
|
|
2022
Q4 | $81.6K | Hold |
34,714
| – | – | ﹤0.01% | 5103 |
|
|
2022
Q3 | $149K | Buy |
34,714
+4
| +0% | +$22 | ﹤0.01% | 5052 |
|
|
2022
Q2 | $141K | Sell |
34,710
-2
| -0% | -$11 | ﹤0.01% | 5131 |
|
|
2022
Q1 | $299K | Hold |
34,712
| – | – | ﹤0.01% | 5018 |
|
|
2021
Q4 | $396K | Hold |
34,712
| – | – | ﹤0.01% | 4940 |
|
|
2021
Q3 | $607K | Hold |
34,712
| – | – | ﹤0.01% | 4703 |
|
|
2021
Q2 | $644K | Sell |
34,712
-8,708
| -20% | -$166K | ﹤0.01% | 4629 |
|
|
2021
Q1 | $1.08M | Buy |
43,420
+43,393
| +160,715% | +$1.3M | ﹤0.01% | 4478 |
|
|
2020
Q4 | $1K | Hold |
27
| – | – | ﹤0.01% | 5041 |
|
|
2020
Q3 | $1K | Hold |
27
| – | – | ﹤0.01% | 5032 |
|
|
2020
Q2 | $1K | Hold |
27
| – | – | ﹤0.01% | 4993 |
|
|
2020
Q1 | $1K | Hold |
27
| – | – | ﹤0.01% | 4948 |
|
|
2019
Q4 | $4K | Hold |
27
| – | – | ﹤0.01% | 4829 |
|
|
2019
Q3 | $10K | Hold |
27
| – | – | ﹤0.01% | 4724 |
|
|
2019
Q2 | $14K | Hold |
27
| – | – | ﹤0.01% | 4732 |
|
|
2019
Q1 | $31K | Hold |
27
| – | – | ﹤0.01% | 4545 |
|
|
2018
Q4 | $30K | Hold |
27
| – | – | ﹤0.01% | 4544 |
|
|
2018
Q3 | $40K | Hold |
27
| – | – | ﹤0.01% | 4573 |
|
|
2018
Q2 | $34K | Sell |
27
-4
| -13% | -$21.9K | ﹤0.01% | 4607 |
|
|
2018
Q1 | $307K | Hold |
31
| – | – | ﹤0.01% | 4122 |
|
|
2017
Q4 | $446K | Hold |
31
| – | – | ﹤0.01% | 4070 |
|
|
2017
Q3 | $835K | Hold |
31
| – | – | ﹤0.01% | 3961 |
|
|
2017
Q2 | $1.58M | Sell |
31
-73
| -70% | -$3.99M | ﹤0.01% | 3744 |
|
|
2017
Q1 | $7.92M | Buy |
+104
| New | +$8.4M | ﹤0.01% | 3215 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3402 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3345 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3401 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3056 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3184 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 2975 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 2754 |
|
Other funds holding NVIV
BlackRock's NVIV Position: Q1 2024 in Review
BlackRock sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q1 2024, closing a stake of 34,714 shares — an estimated $25.3K sold.
BlackRock first reported a position in NVIV in Q1 2017 and held it in 28 quarters. The position peaked at $7.92M in Q1 2017. 4 funds tracked by Wall St. Rank hold NVIV as of Q1 2024.
- BlackRock reported no remaining InVivo Therapeutics Holdings Corp position as of Q1 2024 after selling out during the quarter.
- BlackRock sold 34,714 InVivo Therapeutics Holdings Corp shares in Q1 2024, an estimated $25.3K.
- BlackRock first reported a position in InVivo Therapeutics Holdings Corp in Q1 2017 and held it in 28 quarters.
- BlackRock's InVivo Therapeutics Holdings Corp position peaked at $7.92M in Q1 2017.
- 4 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q1 2024.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.